Virgilijus Uloza

Prof. Virgilijus Uloza

Lithuanian University of Health Sciences, Kaunas, Kauno Miestas, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
RMRytis Maskeliūnas
Rytis Maskeliūnas
RDRobertas Damaševičius
Robertas Damaševičius
AKAudrius Kulikajevas
Audrius Kulikajevas
EPEvaldas Padervinskis
Evaldas Padervinskis
KPKipras Pribuišis
Kipras Pribuišis
VUVirgilijus Uloza
Virgilijus Uloza
Speech impairment analysis and processing technologies have evolved substantially in recent years, and the use of voice as a biomarker has gained popularity. We have developed an approach for clinical speech signal processing to demonstrate the promise of deep learning-driven voice analysis as a screening tool for Parkinson’s Disease (PD), the world’s second most prevalent neurodegenerative disease. Detecting Parkinson’s disease symptoms typically involves an evaluation by a movement disorder expert, which can be difficult to get and yield varied findings. A vocal digital biomarker might supplement the time-consuming traditional manual examination by recognizing and evaluating symptoms that characterize voice quality and level of deterioration. We present a deep learning based, custom U-lossian model for PD assessment and recognition. The study’s goal was to discover anomalies in the PD-affected voice and develop an automated screening method that can discriminate between the voices of PD patients and healthy volunteers while also providing a voice quality score. The classification accuracy was evaluated on two speech corpora (Italian PVS and own Lithuanian PD voice dataset) and we have found the result to be medically appropriate, with values of 0.8964 and 0.7949, confirming the proposed model’s high generalizability.

11 October 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
VUVirgilijus Uloza
Virgilijus Uloza
AKAlina Kuzminienė
Alina Kuzminienė
SŠSonata Šalomskaitė-Davalgienė
Sonata Šalomskaitė-Davalgienė
JPJolita Palubinskienė
Jolita Palubinskienė
IBIngrida Balnytė
Ingrida Balnytė
AVAngelija Valančiūtė
Angelija Valančiūtė
Background. The aim of this study was to develop chick embryo chorioallantoic membrane (CAM) model of laryngeal squamous cell carcinoma (LSCC) and to evaluate the morphological and morphometric characteristics and angiogenic features of it.Methods. Fresh LSCC tissue samples obtained from 6 patients were implanted onto 15 chick embryo CAMs. Morphological, morphometric, and angiogenic changes in the CAM and chorionic epithelium were evaluated up to 4 days after the tumor implantation. Immunohistochemical analysis (34βE12, CD31, and Ki67 staining) was performed to detect cytokeratins and tumor endothelial cells and to evaluate the proliferative capacity of the tumor before and after implantation on the CAM.Results. The implanted LSCC tissue samples survived on the CAM in all the experiments and retained the essential morphologic characteristics and proliferative capacity of the original tumor. Implants induced thickening of both the CAM (103–417%,p=0.0001) and the chorionic epithelium (70–140%,p=0.0001) and increase in number of blood vessels (75–148%,p=0.0001) in the CAM.Conclusions. This study clarifies that chick embryo CAM is a relevant assay for implanting LSCC tissue and provides the first morphological and morphometric characterization of the LSCC CAM model that opens new perspectives to study this disease.

11 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
RMRytis Maskeliūnas
Rytis Maskeliūnas
AKAudrius Kulikajevas
Audrius Kulikajevas
RDRobertas Damaševičius
Robertas Damaševičius
KPKipras Pribuišis
Kipras Pribuišis
NUNora Ulozaitė-Stanienė
Nora Ulozaitė-Stanienė
VUVirgilijus Uloza
Virgilijus Uloza
Laryngeal carcinoma is the most common malignant tumor of the upper respiratory tract. Total laryngectomy provides complete and permanent detachment of the upper and lower airways that causes the loss of voice, leading to a patient’s inability to verbally communicate in the postoperative period. This paper aims to exploit modern areas of deep learning research to objectively classify, extract and measure the substitution voicing after laryngeal oncosurgery from the audio signal. We propose using well-known convolutional neural networks (CNNs) applied for image classification for the analysis of voice audio signal. Our approach takes an input of Mel-frequency spectrogram (MFCC) as an input of deep neural network architecture. A database of digital speech recordings of 367 male subjects (279 normal speech samples and 88 pathological speech samples) was used. Our approach has shown the best true-positive rate of any of the compared state-of-the-art approaches, achieving an overall accuracy of 89.47%.

23 December 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VUVirgilijus Uloza
Virgilijus Uloza
KPKipras Pribuišis
Kipras Pribuišis
NUNora Ulozaitė-Stanienė
Nora Ulozaitė-Stanienė
TPTadas Petrauskas
Tadas Petrauskas
RDRobertas Damaševičius
Robertas Damaševičius
RMRytis Maskeliūnas
Rytis Maskeliūnas
The study aimed to investigate and compare the accuracy and robustness of the multiparametric acoustic voice indices (MAVIs), namely the Dysphonia Severity Index (DSI), Acoustic Voice Quality Index (AVQI), Acoustic Breathiness Index (ABI), and Voice Wellness Index (VWI) measures in differentiating normal and dysphonic voices. The study group consisted of 129 adult individuals including 49 with normal voices and 80 patients with pathological voices. The diagnostic accuracy of the investigated MAVI in differentiating between normal and pathological voices was assessed using receiver operating characteristics (ROC). Moderate to strong positive linear correlations were observed between different MAVIs. The ROC statistical analysis revealed that all used measurements manifested in a high level of accuracy (area under the curve (AUC) of 0.80 and greater) and an acceptable level of sensitivity and specificity in discriminating between normal and pathological voices. However, with AUC 0.99, the VWI demonstrated the highest diagnostic accuracy. The highest Youden index equaled 0.93, revealing that a VWI cut-off of 4.45 corresponds with highly acceptable sensitivity (97.50%) and specificity (95.92%). In conclusion, the VWI was found to be beneficial in describing differences in voice quality status and discriminating between normal and dysphonic voices based on clinical diagnosis, i.e., dysphonia type, implying the VWI’s reliable voice screening potential.

28 September 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
VUVirgilijus Uloza
Virgilijus Uloza
RMRytis Maskeliūnas
Rytis Maskeliūnas
KPKipras Pribuišis
Kipras Pribuišis
SVSaulius Vaitkus
Saulius Vaitkus
AKAudrius Kulikajevas
Audrius Kulikajevas
RDRobertas Damasevicius
Robertas Damasevicius
The purpose of this research was to develop an artificial intelligence-based method for evaluating substitution voicing (SV) and speech following laryngeal oncosurgery. Convolutional neural networks were used to analyze spoken audio sources. A Mel-frequency spectrogram was employed as input to the deep neural network architecture. The program was trained using a collection of 309 digitized speech recordings. The acoustic substitution voicing index (ASVI) model was elaborated using regression analysis. This model was then tested with speech samples that were unknown to the algorithm, and the results were compared to the auditory-perceptual SV evaluation provided by the medical professionals. A statistically significant, strong correlation with rs = 0.863 (p = 0.001) was observed between the ASVI and the SV evaluation performed by the trained laryngologists. The one-way ANOVA showed statistically significant ASVI differences in control, cordectomy, partial laryngectomy, and total laryngectomy patient groups (p < 0.001). The elaborated lightweight ASVI algorithm reached rapid response rates of 3.56 ms. The ASVI provides a fast and efficient option for SV and speech in patients after laryngeal oncosurgery. The ASVI results are comparable to the auditory-perceptual SV evaluation performed by medical professionals.

9 March 2021 in Cells
Verified
Journal Article
Open access
PDF file
APAgnė Pašvenskaitė
Agnė Pašvenskaitė
RLRasa Liutkeviciene
Rasa Liutkeviciene
GGGreta Gedvilaite-Vaicechauskiene
Greta Gedvilaite-Vaicechauskiene
Alvita Vilkeviciute-PetraiteAlvita Vilkeviciute-Petraite
Alvita Vilkeviciute-Petraite
VLVykintas Liutkevicius
Vykintas Liutkevicius
VUVirgilijus Uloza
Virgilijus Uloza
Recent studies have described the dichotomous function of IL-9 in various cancer diseases. However, its function has still not been analysed in laryngeal squamous cell carcinoma (LSCC). In the present study, we evaluated five single nucleotide polymorphisms (SNPs) of IL-9 (rs1859430, rs2069870, rs11741137, rs2069885, and rs2069884) and determined their associations with the patients’ five-year survival rate. Additionally, we analysed serum IL-9 levels using an enzyme-linked immunosorbent assay. Three hundred LSCC patients and 533 control subjects were included in this study. A significant association between the patients’ survival rate and distribution of IL-9 rs1859430 variants was revealed: patients carrying AA genotype had a higher risk of dying (p = 0.005). Haplotypes A-G-C-G-G of IL-9 (rs1859430, rs2069870, rs11741137, rs2069885, and rs2069884) were associated with 47% lower odds of LSCC occurrence (p = 0.035). Serum IL-9 levels were found detectable in three control group subjects (8.99 ± 12.03 pg/mL). In summary, these findings indicate that the genotypic distribution of IL-9 rs1859430 negatively influences the five-year survival rate of LSCC patients. The haplotypes A-G-C-G-G of IL-9 (rs1859430, rs2069870, rs11741137, rs2069885, and rs2069884) are associated with the lower odds of LSCC development.